{"id":895,"date":"2024-01-22T13:24:40","date_gmt":"2024-02-01T13:27:48","guid":{"rendered":"https:\/\/devm.kyowakirininternational.com\/?page_id=895"},"modified":"2025-10-09T14:56:17","modified_gmt":"2025-10-09T13:56:17","slug":"areas-de-foco","status":"publish","type":"page","link":"https:\/\/kyowakirininternational.com\/pt-pt\/o-que-fazemos\/areas-de-foco\/","title":{"rendered":"\u00c1reas de foco"},"content":{"rendered":"<p>[et_pb_section fb_built=&#8221;1&#8243; admin_label=&#8221;Section&#8221; _builder_version=&#8221;4.24.3&#8243; _module_preset=&#8221;default&#8221; background_color=&#8221;#FFFFFF&#8221; custom_margin=&#8221;25px||-30px||false|false&#8221; global_module=&#8221;692&#8243; saved_tabs=&#8221;all&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_row column_structure=&#8221;1_3,1_3,1_3&#8243; _builder_version=&#8221;4.26.1&#8243; _module_preset=&#8221;default&#8221; background_color=&#8221;#e5e5e5&#8243; width=&#8221;100%&#8221; max_width=&#8221;100%&#8221; custom_margin=&#8221;-55px||||false|false&#8221; custom_margin_tablet=&#8221;&#8221; custom_margin_phone=&#8221;&#8221; custom_margin_last_edited=&#8221;on|desktop&#8221; custom_padding=&#8221;0px|0px|0px|0px|false|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_3&#8243; admin_label=&#8221;Column&#8221; _builder_version=&#8221;4.24.3&#8243; _module_preset=&#8221;default&#8221; custom_padding=&#8221;25px|||5px|false|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text content_tablet=&#8221; <\/p>\n<p style=%22text-align: center;%22><a href=%22https:\/\/www.kyowakirinhub.com\/%22 data-et-target-link=%22_blank%22 rel=%22noopener%22><span style=%22color: #ff6600;%22>Healthcare Professionals Hub<\/span><\/a><\/p>\n<p> &#8221; content_phone=&#8221;<\/p>\n<p style=%22text-align: center;%22><a href=%22https:\/\/www.kyowakirinhub.com\/%22 data-et-target-link=%22_blank%22 rel=%22noopener%22><span style=%22color: #ff6600;%22>Healthcare Professionals Hub<\/span><\/a><\/p>\n<p>&#8221; content_last_edited=&#8221;on|phone&#8221; admin_label=&#8221;Text&#8221; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; text_font=&#8221;|700|||||||&#8221; text_text_color=&#8221;#ea5504&#8243; text_orientation=&#8221;center&#8221; custom_margin=&#8221;||||false|false&#8221; custom_margin_tablet=&#8221;&#8221; custom_margin_phone=&#8221;||||false|false&#8221; custom_margin_last_edited=&#8221;on|phone&#8221; custom_padding=&#8221;||||false|false&#8221; link_option_url_new_window=&#8221;on&#8221; text_text_color_tablet=&#8221;&#8221; text_text_color_phone=&#8221;&#8221; text_text_color_last_edited=&#8221;on|phone&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p style=\"text-align: center;\"><a href=\"https:\/\/www.kyowakirinhub.com\/\" target=\"_blank\" rel=\"noopener\"><span style=\"color: #ff6600;\">Plataforma reservada a profissionais de sa\u00fade<\/span><\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_3&#8243; admin_label=&#8221;Column&#8221; _builder_version=&#8221;4.24.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_column][et_pb_column type=&#8221;1_3&#8243; admin_label=&#8221;Column&#8221; _builder_version=&#8221;4.24.0&#8243; _module_preset=&#8221;default&#8221; background_color_phone=&#8221;RGBA(255,255,255,0)&#8221; background_last_edited=&#8221;on|phone&#8221; background_enable_color_phone=&#8221;on&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; text_font=&#8221;|700|||||||&#8221; text_text_color=&#8221;#FFFFFF&#8221; background_color=&#8221;#ea5504&#8243; width=&#8221;100%&#8221; module_alignment=&#8221;center&#8221; custom_margin=&#8221;||||false|false&#8221; custom_margin_tablet=&#8221;&#8221; custom_margin_phone=&#8221;||||false|false&#8221; custom_margin_last_edited=&#8221;on|desktop&#8221; custom_padding=&#8221;10px||||false|false&#8221; link_option_url=&#8221;https:\/\/kyowakirininternational.com\/pt-pt\/global-reporting\/&#8221; link_option_url_new_window=&#8221;on&#8221; border_color_all=&#8221;#FFFFFF&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p style=\"text-align: center;\">Comunica\u00e7\u00e3o de rea\u00e7\u00f5es adversas <img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/kyowakirininternational.com\/pt-pt\/wp-content\/uploads\/sites\/22\/2024\/01\/Link-to-external-1.png\" width=\"26\" height=\"28\" alt=\"\" class=\"wp-image-615 alignnone size-full\" \/><\/p>\n<p style=\"text-align: center;\">[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=&#8221;4.24.0&#8243; _module_preset=&#8221;default&#8221; z_index=&#8221;500&#8243; width=&#8221;100%&#8221; max_width=&#8221;100%&#8221; min_height=&#8221;100px&#8221; height=&#8221;100px&#8221; overflow-x=&#8221;visible&#8221; overflow-y=&#8221;visible&#8221; custom_margin=&#8221;||||false|false&#8221; custom_padding=&#8221;|||25px|false|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.24.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_menu menu_id=&#8221;37&#8243; active_link_color=&#8221;#ea5504&#8243; dropdown_menu_bg_color=&#8221;#5d6164&#8243; dropdown_menu_line_color=&#8221;#ff3300&#8243; dropdown_menu_text_color=&#8221;#000000&#8243; dropdown_menu_active_link_color=&#8221;#ff3300&#8243; mobile_menu_bg_color=&#8221;#b4c0c1&#8243; mobile_menu_text_color=&#8221;#000000&#8243; logo=&#8221;https:\/\/kyowakirininternational.com\/pt-pt\/wp-content\/uploads\/sites\/22\/2024\/01\/KyowaKirin_BrandLogo_colorv2-PhotoRoom-1-1024&#215;216.png&#8221; logo_url=&#8221;https:\/\/kyowakirininternational.com\/pt-pt\/&#8221; logo_width=&#8221;100%&#8221; logo_max_width=&#8221;17%&#8221; show_search_icon=&#8221;on&#8221; search_icon_color=&#8221;#ea5504&#8243; menu_icon_color=&#8221;#ea5504&#8243; logo_max_width_tablet=&#8221;35%&#8221; logo_max_width_phone=&#8221;76%&#8221; logo_max_width_last_edited=&#8221;on|phone&#8221; show_search_icon_tablet=&#8221;on&#8221; show_search_icon_phone=&#8221;on&#8221; show_search_icon_last_edited=&#8221;on|phone&#8221; search_icon_color_tablet=&#8221;#ea5504&#8243; search_icon_color_phone=&#8221;#ea5504&#8243; search_icon_color_last_edited=&#8221;on|phone&#8221; _builder_version=&#8221;4.25.1&#8243; _module_preset=&#8221;default&#8221; menu_font=&#8221;|600|||||||&#8221; menu_text_color=&#8221;#5d6164&#8243; menu_font_size=&#8221;17px&#8221; background_color=&#8221;RGBA(255,255,255,0)&#8221; custom_css_free_form=&#8221;.et_pb_menu__icon.et_pb_menu__search-button {||padding: 2% 2% 2% 1%;||||}&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_menu][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=&#8221;4.24.0&#8243; _module_preset=&#8221;default&#8221; width=&#8221;90%&#8221; max_width=&#8221;100%&#8221; custom_margin=&#8221;-25px||||false|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.24.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][lwp_divi_breadcrumbs home_text=&#8221;P\u00e1gina inicial&#8221; font_icon=&#8221;&#x35;||divi||400&#8243; link_color=&#8221;#5d6164&#8243; separator_color=&#8221;#e95505&#8243; current_text_color=&#8221;#e95505&#8243; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; module_text_align=&#8221;left&#8221; background_color=&#8221;RGBA(255,255,255,0)&#8221; text_orientation=&#8221;left&#8221; animation_style=&#8221;fade&#8221; global_module=&#8221;1047&#8243; global_colors_info=&#8221;{}&#8221;][\/lwp_divi_breadcrumbs][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; admin_label=&#8221;Section&#8221; _builder_version=&#8221;4.24.0&#8243; _module_preset=&#8221;default&#8221; background_color=&#8221;#5d6164&#8243; height=&#8221;50px&#8221; height_tablet=&#8221;100px&#8221; height_phone=&#8221;140px&#8221; height_last_edited=&#8221;on|phone&#8221; custom_margin=&#8221;||||false|false&#8221; custom_padding=&#8221;||||false|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_row _builder_version=&#8221;4.25.1&#8243; _module_preset=&#8221;default&#8221; custom_margin=&#8221;-40px||||false|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.24.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_menu menu_id=&#8221;40&#8243; menu_style=&#8221;centered&#8221; active_link_color=&#8221;#ea5504&#8243; dropdown_menu_line_color=&#8221;#ea5504&#8243; dropdown_menu_active_link_color=&#8221;#ea5504&#8243; mobile_menu_bg_color=&#8221;#b4c0c1&#8243; mobile_menu_text_color=&#8221;#000000&#8243; menu_icon_color=&#8221;#ea5504&#8243; _builder_version=&#8221;4.25.1&#8243; _module_preset=&#8221;default&#8221; menu_text_color=&#8221;#FFFFFF&#8221; menu_font_size=&#8221;15px&#8221; background_color=&#8221;RGBA(255,255,255,0)&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_menu][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; next_background_color=&#8221;#FFFFFF&#8221; admin_label=&#8221;Section&#8221; _builder_version=&#8221;4.24.2&#8243; _module_preset=&#8221;default&#8221; background_color=&#8221;#e5e5e5&#8243; use_background_color_gradient=&#8221;on&#8221; background_color_gradient_stops=&#8221;#e4560b 0%|rgba(228,86,11,0.38) 100%&#8221; background_color_gradient_overlays_image=&#8221;on&#8221; background_image=&#8221;https:\/\/kyowakirininternational.com\/pt-pt\/wp-content\/uploads\/sites\/22\/2024\/03\/SSP1584-1-crop-1.jpg&#8221; bottom_divider_style=&#8221;curve2&#8243; bottom_divider_height=&#8221;48px&#8221; bottom_divider_repeat=&#8221;1x&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_row column_structure=&#8221;1_2,1_2&#8243; _builder_version=&#8221;4.24.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.24.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; header_font=&#8221;|700|||||||&#8221; header_text_color=&#8221;#FFFFFF&#8221; hover_enabled=&#8221;0&#8243; global_colors_info=&#8221;{}&#8221; sticky_enabled=&#8221;0&#8243;]<\/p>\n<h1 style=\"text-align: left;\">As nossas \u00e1reas de foco<\/h1>\n<p>[\/et_pb_text][et_pb_text _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; text_text_color=&#8221;#FFFFFF&#8221; hover_enabled=&#8221;0&#8243; global_colors_info=&#8221;{}&#8221; sticky_enabled=&#8221;0&#8243;]<\/p>\n<p>Como uma empresa farmac\u00eautica global especializada com sede no Jap\u00e3o, estamos empenhados em fornecer medicamentos e tratamentos com valor transformador para pessoas afetadas por doen\u00e7as subdiagnosticadas e mal atendidas.<\/p>\n<p>Com experi\u00eancia em levar produtos \u00abda linha de produ\u00e7\u00e3o aos doentes\u00bb, utilizamos a nossa expertise para maximizar o impacto dos nossos medicamentos e tecnologias em v\u00e1rias \u00e1reas terap\u00eauticas.<\/p>\n<p>&nbsp;<\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.24.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_testimonial author=&#8221;Dr Nick Kronfeld&#8221; job_title=&#8221;Head of Medical Affairs&#8221; company_name=&#8221;Kyowa Kirin International (KKI)&#8221; portrait_url=&#8221;https:\/\/kyowakirininternational.com\/pt-pt\/wp-content\/uploads\/sites\/22\/2024\/04\/Dr-Nick-scaled-1.jpg&#8221; quote_icon_color=&#8221;#FFFFFF&#8221; quote_icon_background_color=&#8221;#ea5504&#8243; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; body_text_color=&#8221;#FFFFFF&#8221; author_text_color=&#8221;#FFFFFF&#8221; position_text_color=&#8221;#FFFFFF&#8221; company_text_color=&#8221;#FFFFFF&#8221; background_enable_color=&#8221;off&#8221; use_background_color_gradient=&#8221;on&#8221; background_color_gradient_stops=&#8221;#e55000 0%|rgba(229,87,10,0.58) 100%&#8221; background_color_gradient_overlays_image=&#8221;on&#8221; animation_style=&#8221;slide&#8221; animation_delay=&#8221;200ms&#8221; hover_enabled=&#8221;0&#8243; border_color_all=&#8221;RGBA(255,255,255,0)&#8221; global_colors_info=&#8221;{}&#8221; sticky_enabled=&#8221;0&#8243;]<\/p>\n<p>Estamos empenhados em encontrar solu\u00e7\u00f5es novas e inovadoras para tratar algumas das doen\u00e7as mais raras do mundo. Esfor\u00e7amo-nos por melhorar a vida dos pacientes e faz\u00ea-los sorrir.<\/p>\n<p>[\/et_pb_testimonial][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; next_background_color=&#8221;#dbdbdb&#8221; admin_label=&#8221;Section&#8221; _builder_version=&#8221;4.24.2&#8243; _module_preset=&#8221;default&#8221; background_color=&#8221;#FFFFFF&#8221; bottom_divider_style=&#8221;mountains2&#8243; bottom_divider_height=&#8221;29px&#8221; bottom_divider_repeat=&#8221;1x&#8221; bottom_divider_flip=&#8221;vertical&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_row _builder_version=&#8221;4.24.2&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.24.2&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; header_3_text_color=&#8221;#ea5504&#8243; link_option_url=&#8221;#ctcl&#8221; hover_enabled=&#8221;0&#8243; global_colors_info=&#8221;{}&#8221; sticky_enabled=&#8221;0&#8243;]<\/p>\n<h3><strong>Linfoma cut\u00e2neo de c\u00e9lulas T ( LCCT) <\/strong><\/h3>\n<p>O linfoma cut\u00e2neo de c\u00e9lulas T, ou LCCT, \u00e9 uma forma rara de linfoma n\u00e3o Hodgkin, um tipo de cancro do sangue, que ocorre quando o corpo produz demasiados gl\u00f3bulos brancos (especificamente c\u00e9lulas T).<\/p>\n<p>[\/et_pb_text][et_pb_text _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; header_3_text_color=&#8221;#ea5504&#8243; link_option_url=&#8221;#xlh&#8221; hover_enabled=&#8221;0&#8243; global_colors_info=&#8221;{}&#8221; sticky_enabled=&#8221;0&#8243;]<\/p>\n<h3><strong>Hipofosfatemia ligada ao cromossoma X (XLH)<\/strong><\/h3>\n<p>A hipofosfatemia ligada ao cromossoma X, ou XLH, \u00e9 uma doen\u00e7a musculoesquel\u00e9tica rara e heredit\u00e1ria causada pela falta de fosfato.<\/p>\n<p>[\/et_pb_text][et_pb_text _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; header_3_text_color=&#8221;#ea5504&#8243; link_option_url=&#8221;#tio&#8221; hover_enabled=&#8221;0&#8243; global_colors_info=&#8221;{}&#8221; sticky_enabled=&#8221;0&#8243;]<\/p>\n<h3><strong>Osteomal\u00e1cia induzida por tumor (TIO) <\/strong><\/h3>\n<p>A osteomal\u00e1cia induzida por tumor, ou TIO, \u00e9 uma doen\u00e7a rara e adquirida do metabolismo do fosfato e da vitamina D causada por tumores end\u00f3crinos tipicamente pequenos.<\/p>\n<p>[\/et_pb_text][et_pb_text _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; header_3_text_color=&#8221;#ea5504&#8243; link_option_url=&#8221;#mld&#8221; hover_enabled=&#8221;0&#8243; global_colors_info=&#8221;{}&#8221; sticky_enabled=&#8221;0&#8243;]<\/p>\n<h3><strong>Leucodistrofia metacrom\u00e1tica (MLD) <\/strong><\/h3>\n<p>A leucodistrofia metacrom\u00e1tica, ou MLD, \u00e9 uma doen\u00e7a heredit\u00e1ria rara e potencialmente fatal do sistema metab\u00f3lico do organismo.<\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; admin_label=&#8221;Section&#8221; module_id=&#8221;ctcl&#8221; _builder_version=&#8221;4.24.2&#8243; _module_preset=&#8221;default&#8221; background_color=&#8221;#dbdbdb&#8221; bottom_divider_style=&#8221;mountains2&#8243; bottom_divider_color=&#8221;#b7b7b7&#8243; bottom_divider_height=&#8221;24px&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_row _builder_version=&#8221;4.24.2&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.24.2&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; header_text_color=&#8221;#ea5504&#8243; hover_enabled=&#8221;0&#8243; global_colors_info=&#8221;{}&#8221; sticky_enabled=&#8221;0&#8243;]<\/p>\n<h1 style=\"text-align: center;\">Linfoma cut\u00e2neo de c\u00e9lulas T ( LCCT)<\/h1>\n<p>[\/et_pb_text][et_pb_image src=&#8221;https:\/\/kyowakirininternational.com\/pt-pt\/wp-content\/uploads\/sites\/22\/2024\/05\/Hematology-Oncology-300&#215;200-1.png&#8221; alt=&#8221;Haemato-Oncology&#8221; title_text=&#8221;Hematology-Oncology-300&#215;200&#8243; align=&#8221;center&#8221; _builder_version=&#8221;4.25.1&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_image][et_pb_text _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; header_4_text_color=&#8221;#ea5504&#8243; hover_enabled=&#8221;0&#8243; global_colors_info=&#8221;{}&#8221; sticky_enabled=&#8221;0&#8243;]<\/p>\n<p>O linfoma cut\u00e2neo de c\u00e9lulas T ( LCCT ) \u00e9 uma forma rara de linfoma n\u00e3o Hodgkin, um tipo de cancro do sangue, que ocorre quando o corpo produz demasiados gl\u00f3bulos brancos (especificamente c\u00e9lulas T).<\/p>\n<p>As c\u00e9lulas T fazem parte do sistema imunit\u00e1rio e ajudam o corpo a combater doen\u00e7as ou infe\u00e7\u00f5es. Algumas c\u00e9lulas T desempenham a sua fun\u00e7\u00e3o imunit\u00e1ria na pele e, no caso do LCCT, as c\u00e9lulas T cancerosas acumulam-se no \u00f3rg\u00e3o cut\u00e2neo e podem muitas vezes parecer uma erup\u00e7\u00e3o cut\u00e2nea ou uma placa elevada.<\/p>\n<p>\u00c9 importante compreender que o LCCT \u00e9 um cancro do sangue, mesmo que afete inicialmente a pele.<\/p>\n<h4><strong><\/strong><\/h4>\n<h4><strong>DIFERENTES TIPOS DE LCCT <\/strong><\/h4>\n<p>Existem v\u00e1rios tipos de LCCT que podem ter apar\u00eancias diferentes na pele, afetar diferentes partes do corpo e progredir em velocidades diferentes. Os tipos mais conhecidos s\u00e3o chamados de micose fung\u00f3ide e s\u00edndrome de S\u00e9zary.<\/p>\n<p>A micose fung\u00f3ide \u00e9 geralmente considerada como uma doen\u00e7a de progress\u00e3o lenta. \u00c9 a forma mais comum de LCCT, representando cerca de 60% dos casos.<\/p>\n<p>A s\u00edndrome de S\u00e9zary \u00e9 uma forma mais agressiva de LCCT, diferindo da micose fung\u00f3ide devido ao envolvimento total do \u00f3rg\u00e3o cut\u00e2neo (eritrodermia) e ao maior n\u00famero de c\u00e9lulas T cancerosas detectadas no sangue.<\/p>\n<p>&nbsp;<\/p>\n<h4><strong>O QUE CAUSA O LCCT? <\/strong><\/h4>\n<p>Os especialistas n\u00e3o sabem o que causa o LCCT. No entanto, estudos cient\u00edficos demonstraram que n\u00e3o \u00e9 contagioso (o que significa que n\u00e3o se pode apanh\u00e1-lo de outras pessoas nem transmiti-lo) e \u00e9 improv\u00e1vel que seja gen\u00e9tico.<\/p>\n<h4><strong><\/strong><\/h4>\n<h4><strong>OBTER UM DIAGN\u00d3STICO DE LCCT<\/strong><\/h4>\n<p>O primeiro passo no diagn\u00f3stico do LCCT \u00e9 uma bi\u00f3psia da pele; no entanto, o diagn\u00f3stico nem sempre \u00e9 simples, mesmo para um especialista.<\/p>\n<p>Dada a raridade da doen\u00e7a e a dificuldade em identific\u00e1-la, muitas vezes \u00e9 necess\u00e1ria a opini\u00e3o de m\u00e9dicos de v\u00e1rias especialidades (por exemplo, dermatologia, hematologia e patologia).<\/p>\n<p>Devido ao facto de as les\u00f5es cut\u00e2neas no LCCT serem semelhantes \u00e0s de doen\u00e7as mais comuns, como eczema e psor\u00edase, o diagn\u00f3stico definitivo do LCCT leva, em m\u00e9dia, cerca de tr\u00eas anos; para alguns, isso pode ser mais r\u00e1pido e, para outros, pode levar ainda mais tempo.<\/p>\n<p><strong><\/strong><\/p>\n<h4><strong>VIVER COM LCCT<\/strong><\/h4>\n<p>Viver com LCCT pode afetar o bem-estar emocional de uma pessoa devido ao impacto que a doen\u00e7a tem na sua apar\u00eancia e bem-estar, bem como na sua vida di\u00e1ria. Saiba mais sobre a vida com LCCT <a href=\"https:\/\/ctclanswers.com\/\" target=\"_blank\" rel=\"noopener\">aqui<\/a>.<\/p>\n<p>Existem v\u00e1rias organiza\u00e7\u00f5es para pessoas com LCCT ou outros tipos de cancro raros que podem oferecer conselhos pr\u00e1ticos sobre a vida di\u00e1ria e apoio sobre formas de lidar com os seus sentimentos.<\/p>\n<p><a href=\"https:\/\/www.clfoundation.org\/\" target=\"_blank\" rel=\"noopener\">Clique aqui <\/a> para visitar a Cutaneous Lymphoma Foundation, uma organiza\u00e7\u00e3o de defesa dos doentes que apoia pessoas que vivem com LCCT em todo o mundo.<\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; admin_label=&#8221;Section&#8221; module_id=&#8221;xlh&#8221; _builder_version=&#8221;4.24.2&#8243; _module_preset=&#8221;default&#8221; background_color=&#8221;#dbdbdb&#8221; bottom_divider_style=&#8221;mountains2&#8243; bottom_divider_color=&#8221;#b7b7b7&#8243; bottom_divider_height=&#8221;26px&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_row _builder_version=&#8221;4.24.2&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.24.2&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; header_text_color=&#8221;#ea5504&#8243; hover_enabled=&#8221;0&#8243; global_colors_info=&#8221;{}&#8221; sticky_enabled=&#8221;0&#8243;]<\/p>\n<h1 style=\"text-align: center;\">Hipofosfatemia ligada ao cromossoma X (XLH)<\/h1>\n<p>[\/et_pb_text][et_pb_image src=&#8221;https:\/\/kyowakirininternational.com\/pt-pt\/wp-content\/uploads\/sites\/22\/2024\/04\/Rare-metabolic-disorders-1.jpg&#8221; alt=&#8221;Rare Metabolic Diseases&#8221; title_text=&#8221;Chromosome X and Y&#8221; align=&#8221;center&#8221; _builder_version=&#8221;4.24.3&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_image][et_pb_text _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; header_4_text_color=&#8221;#ea5504&#8243; custom_padding=&#8221;||0px|||&#8221; hover_enabled=&#8221;0&#8243; global_colors_info=&#8221;{}&#8221; sticky_enabled=&#8221;0&#8243;]<\/p>\n<p>A hipofosfatemia ligada ao cromossoma X, ou XLH, \u00e9 uma doen\u00e7a musculoesquel\u00e9tica rara e heredit\u00e1ria causada pela falta de fosfato.<\/p>\n<p>Ao longo da vida, o nosso corpo precisa de fosfato para crescer e se desenvolver adequadamente. O fosfato \u00e9 necess\u00e1rio para a sa\u00fade dos ossos, dentes, sangue e m\u00fasculos, e est\u00e1 envolvido no fornecimento de energia ao nosso corpo. A maior parte do fosfato da nossa dieta acaba nos nossos dentes e ossos, onde, juntamente com o c\u00e1lcio, \u00e9 essencial para a sa\u00fade \u00f3ssea ao longo da vida.<\/p>\n<p>A XLH \u00e9 uma doen\u00e7a cr\u00f3nica que afeta crian\u00e7as e adultos de forma diferente, com sintomas que variam de pessoa para pessoa. Estes podem incluir pseudofraturas, osteoartrite, dores nas articula\u00e7\u00f5es e nos ossos e problemas dent\u00e1rios. <\/p>\n<h4><strong><\/strong><\/h4>\n<h4><strong>O QUE CAUSA A XLH? <\/strong><\/h4>\n<p>A XLH \u00e9 uma condi\u00e7\u00e3o gen\u00e9tica que ocorre devido a uma muta\u00e7\u00e3o no cromossoma X. Esta muta\u00e7\u00e3o cria um excesso do fator de crescimento fibrobl\u00e1stico 23 (FGF23), o que faz com que os rins da pessoa deixem passar demasiado fosfato na urina. Esta \u00abperda de fosfato\u00bb leva a baixos n\u00edveis de f\u00f3sforo no sangue (tamb\u00e9m conhecido como hipofosfatemia).<\/p>\n<p>A maioria das pessoas com XLH herda a muta\u00e7\u00e3o ligada ao cromossoma X de um dos pais. No entanto, uma em cada tr\u00eas pessoas com XLH nasce com a doen\u00e7a, apesar de n\u00e3o haver hist\u00f3rico familiar. Isso \u00e9 chamado de \u00abXLH espont\u00e2nea\u00bb. Ainda n\u00e3o se sabe por que isso acontece.<\/p>\n<h4><strong><\/strong><\/h4>\n<h4><strong>DIAGN\u00d3STICO DA XLH <\/strong><\/h4>\n<p>A XLH \u00e9 normalmente diagnosticada em idade precoce, por volta da \u00e9poca em que come\u00e7amos a andar. Os sinais comuns s\u00e3o baixa estatura, pernas arqueadas ou joelhos valgos e pulsos ou joelhos que parecem maiores do que o normal.<\/p>\n<p>Por ser uma condi\u00e7\u00e3o t\u00e3o rara, a XLH pode ser confundida com outras doen\u00e7as esquel\u00e9ticas, incluindo o raquitismo nutricional, que \u00e9 causado pela ingest\u00e3o insuficiente de alimentos ricos em vitamina D.<\/p>\n<h4><strong><\/strong><\/h4>\n<h4><strong>VIVER COM XLH<\/strong><\/h4>\n<p>A XLH \u00e9 uma doen\u00e7a cr\u00f3nica, na qual os sintomas e a sua gravidade podem mudar ao longo do tempo. No entanto, existem muitas maneiras pelas quais as pessoas com XLH podem ter uma vida plena e ativa.<\/p>\n<p>E, apesar da raridade da XLH, existem muitos profissionais de sa\u00fade especializados e grupos de apoio que podem fornecer informa\u00e7\u00f5es, ajuda e aconselhamento.<\/p>\n<p><a href=\"https:\/\/xlhalliance.org\/\" target=\"_blank\" rel=\"noopener\">Clique aqui<\/a> para visitar a International XLH Alliance, uma alian\u00e7a internacional de grupos de doentes para pessoas afetadas pela XLH e doen\u00e7as relacionadas.<\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; admin_label=&#8221;Section&#8221; module_id=&#8221;tio&#8221; _builder_version=&#8221;4.24.2&#8243; _module_preset=&#8221;default&#8221; background_color=&#8221;#dbdbdb&#8221; bottom_divider_style=&#8221;mountains2&#8243; bottom_divider_color=&#8221;#b7b7b7&#8243; bottom_divider_height=&#8221;41px&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_row _builder_version=&#8221;4.24.2&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.24.2&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; header_text_color=&#8221;#ea5504&#8243; hover_enabled=&#8221;0&#8243; global_colors_info=&#8221;{}&#8221; sticky_enabled=&#8221;0&#8243;]<\/p>\n<h1 style=\"text-align: center;\">Osteomal\u00e1cia induzida por tumor (TIO)<\/h1>\n<p>[\/et_pb_text][et_pb_image src=&#8221;https:\/\/kyowakirininternational.com\/pt-pt\/wp-content\/uploads\/sites\/22\/2024\/04\/TIO_-1.png&#8221; title_text=&#8221;TIO_&#8221; align=&#8221;center&#8221; _builder_version=&#8221;4.24.3&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_image][et_pb_text _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; header_4_text_color=&#8221;#ea5504&#8243; hover_enabled=&#8221;0&#8243; global_colors_info=&#8221;{}&#8221; sticky_enabled=&#8221;0&#8243;]<\/p>\n<p>A osteomal\u00e1cia induzida por tumor, ou TIO, \u00e9 uma doen\u00e7a rara e adquirida do metabolismo do fosfato e da vitamina D, causada por tumores end\u00f3crinos geralmente pequenos.<\/p>\n<p>A TIO \u00e9 caracterizada por dor \u00f3ssea, fadiga, fraqueza muscular, dist\u00farbios da marcha e m\u00faltiplas fraturas, que podem levar a incapacidade a longo prazo e morbidade prolongada.<\/p>\n<h4><strong>O QUE CAUSA A TIO?<\/strong><\/h4>\n<p>Na TIO, pequenos tumores end\u00f3crinos secretam o fator de crescimento fibrobl\u00e1stico 23 (FGF23), que faz com que os rins da pessoa deixem passar demasiado fosfato na urina. Esta \u00abperda de fosfato\u00bb leva a baixos n\u00edveis de fosfato no sangue (tamb\u00e9m conhecido como hipofosfatemia), o que afeta o metabolismo \u00f3sseo, entre outros.<\/p>\n<h4><strong>DIAGNOSTICAR A TIO<\/strong><\/h4>\n<p>Os sinais e sintomas da TIO n\u00e3o s\u00e3o espec\u00edficos para esta condi\u00e7\u00e3o e, consequentemente, &gt;95% dos casos podem ser diagnosticados incorretamente e tratados de forma inadequada. As pessoas com TIO podem muitas vezes esperar v\u00e1rios anos para receber um diagn\u00f3stico preciso.<\/p>\n<p>&nbsp;<\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; admin_label=&#8221;Section&#8221; module_id=&#8221;mld&#8221; _builder_version=&#8221;4.24.2&#8243; _module_preset=&#8221;default&#8221; background_color=&#8221;#dbdbdb&#8221; bottom_divider_style=&#8221;slant2&#8243; bottom_divider_color=&#8221;#b7b7b7&#8243; bottom_divider_height=&#8221;30px&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_row _builder_version=&#8221;4.24.2&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.24.2&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; header_text_color=&#8221;#ea5504&#8243; hover_enabled=&#8221;0&#8243; global_colors_info=&#8221;{}&#8221; sticky_enabled=&#8221;0&#8243;]<\/p>\n<h1 style=\"text-align: center;\">Leucodistrofia metacrom\u00e1tica (MLD)<\/h1>\n<p>[\/et_pb_text][et_pb_image src=&#8221;https:\/\/kyowakirininternational.com\/pt-pt\/wp-content\/uploads\/sites\/22\/2024\/04\/Gene-therapy-1.jpg&#8221; alt=&#8221;Gene Therapy&#8221; title_text=&#8221;Genetic mutation, conceptual illustration&#8221; align=&#8221;center&#8221; _builder_version=&#8221;4.24.3&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_image][et_pb_text _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; header_4_text_color=&#8221;#ea5504&#8243; hover_enabled=&#8221;0&#8243; global_colors_info=&#8221;{}&#8221; sticky_enabled=&#8221;0&#8243;]<\/p>\n<p>A leucodistrofia metacrom\u00e1tica (MLD) \u00e9 uma doen\u00e7a heredit\u00e1ria rara e potencialmente fatal do sistema metab\u00f3lico do corpo.<\/p>\n<p><i><span data-contrast=\"none\"><\/span><\/i><\/p>\n<h4><strong>O QUE CAUSA A MLD?<\/strong><\/h4>\n<p>A MLD \u00e9 causada por uma muta\u00e7\u00e3o no gene ARSA que resulta na acumula\u00e7\u00e3o de gorduras, chamadas sulfat\u00eddeos, no c\u00e9rebro e em outras \u00e1reas do corpo, incluindo o f\u00edgado, a ves\u00edcula biliar e os rins.<\/p>\n<p>Com o tempo, o sistema nervoso \u00e9 danificado e as crian\u00e7as com MLD apresentam problemas neurol\u00f3gicos, como regress\u00e3o motora, comportamental e cognitiva, espasticidade grave e convuls\u00f5es, e t\u00eam cada vez mais dificuldade para se mover, falar, engolir, comer e ver.<\/p>\n<p><i><span data-contrast=\"none\"><\/span><\/i><\/p>\n<h4><strong>O PESO DA MLD <\/strong><\/h4>\n<p>Estima-se que a MLD ocorra em aproximadamente um em cada 100 000 nascidos vivos. Estima-se que 50% das crian\u00e7as com a forma mais agressiva de MLD morram dentro de cinco anos ap\u00f3s o in\u00edcio da doen\u00e7a, se n\u00e3o forem tratadas.<\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;4.24.2&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_row _builder_version=&#8221;4.24.2&#8243; _module_preset=&#8221;default&#8221; background_color=&#8221;RGBA(255,255,255,0)&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.24.2&#8243; _module_preset=&#8221;default&#8221; background_color=&#8221;RGBA(255,255,255,0)&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.26.0&#8243; _module_preset=&#8221;default&#8221; header_font=&#8221;|700|||||||&#8221; header_text_color=&#8221;#ea5504&#8243; background_color=&#8221;#FFFFFF&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h1 style=\"text-align: center;\">Sources<\/h1>\n<p>\u200b<\/p>\n<ul>\n<li>Macmillan Cancer Support. Cutaneous T-cell lymphoma (CTCL). Available at: <a href=\"https:\/\/jpn01.safelinks.protection.outlook.com\/?url=https%3A%2F%2Fwww.macmillan.org.uk%2Fcancer-information-and-support%2Flymphoma%2Fnon-hodgkin%2Ftypes%2Fcutaneous-t-cell&amp;data=05%7C02%7CChris.Howden%40kyowakirin.com%7C4f8d0ac64ffe49b05a3e08dc8621f826%7C34db9a5d91ba486ebb82d37d2ee1d84c%7C0%7C0%7C638532727790067148%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C0%7C%7C%7C&amp;sdata=v7YiVdzosfACMDV3I0WZ5eMHrnxpVqD%2F98c7ELE4lME%3D&amp;reserved=0\" target=\"_blank\" rel=\"noopener\">https:\/\/www.macmillan.org.uk\/cancer-information-and-support\/lymphoma\/non-hodgkin\/types\/cutaneous-t-cell<\/a> Accessed July 2024.<\/li>\n<li>Lymphoma Action. 2022. Skin (cutaneous) T-cell lymphoma. Available at: <a href=\"https:\/\/jpn01.safelinks.protection.outlook.com\/?url=https%3A%2F%2Flymphoma-action.org.uk%2Ftypes-lymphoma-skin-lymphoma%2Fskin-cutaneous-t-cell-lymphoma%23diagnosis&amp;data=05%7C02%7CChris.Howden%40kyowakirin.com%7C4f8d0ac64ffe49b05a3e08dc8621f826%7C34db9a5d91ba486ebb82d37d2ee1d84c%7C0%7C0%7C638532727790077450%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C0%7C%7C%7C&amp;sdata=y0xGv5OvT6fdTgWDVBVjUGD%2FOry2i2IvxYUSK0YkzK4%3D&amp;reserved=0\" target=\"_blank\" rel=\"noopener\">https:\/\/lymphoma-action.org.uk\/types-lymphoma-skin-lymphoma\/skin-cutaneous-t-cell-lymphoma#diagnosis<\/a> Accessed July 2024.<\/li>\n<li>Walia, Ritika, and Yeung. \u2018An Update on Molecular Biology of Cutaneous T Cell Lymphoma.\u2019 Frontiers in oncology, vol. 9, January 2020, <a href=\"https:\/\/www.frontiersin.org\/journals\/oncology\/articles\/10.3389\/fonc.2019.01558\/full\" target=\"_blank\" rel=\"noopener\">https:\/\/doi.org\/10.3389\/fonc.2019.01558<\/a> Accessed July 2024<\/li>\n<li>Kyowa Kirin. 2020. XLHLink. Available at: <a href=\"https:\/\/jpn01.safelinks.protection.outlook.com\/?url=https%3A%2F%2Fxlhlink.eu%2Findex.html&amp;data=05%7C02%7CChris.Howden%40kyowakirin.com%7C4f8d0ac64ffe49b05a3e08dc8621f826%7C34db9a5d91ba486ebb82d37d2ee1d84c%7C0%7C0%7C638532727790082028%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C0%7C%7C%7C&amp;sdata=OX0FRXyKTjvGSc72flEqysdREoHnzxPyiWqxFOoRvlA%3D&amp;reserved=0\" target=\"_blank\" rel=\"noopener\">https:\/\/xlhlink.eu\/index.html<\/a> Accessed July 2024.<\/li>\n<li>Dahir, Kathryn, et al. &#8216;Diagnosis and Management of Tumor-Induced Osteomalacia: Perspectives from Clinical Experience.&#8217; Journal of the Endocrine Society, vol. 5, no. 9, June 2021, <a href=\"https:\/\/jpn01.safelinks.protection.outlook.com\/?url=https%3A%2F%2Fdoi.org%2F10.1210%2Fjendso%2Fbvab099&amp;data=05%7C02%7CChris.Howden%40kyowakirin.com%7C4f8d0ac64ffe49b05a3e08dc8621f826%7C34db9a5d91ba486ebb82d37d2ee1d84c%7C0%7C0%7C638532727790087250%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C0%7C%7C%7C&amp;sdata=jGgxfb0eot7mQGd9PUNhDugoe5iLQmAFGSko2j1r3EA%3D&amp;reserved=0\" target=\"_blank\" rel=\"noopener\">https:\/\/doi.org\/10.1210\/jendso\/bvab099<\/a>. Accessed July 2024<\/li>\n<li>Orchard Therapeutics. 2020. Neurometabolic Disorders. Available at: <a href=\"https:\/\/orchard-tx.com\/focus\/#MLD\" target=\"_blank\" rel=\"noopener\">https:\/\/orchard-tx.com\/focus\/#MLD<\/a> Accessed July 2024.<\/li>\n<\/ul>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; admin_label=&#8221;Section&#8221; _builder_version=&#8221;4.24.2&#8243; _module_preset=&#8221;default&#8221; background_color=&#8221;#5d6164&#8243; custom_margin=&#8221;||||false|false&#8221; top_divider_style=&#8221;curve&#8221; top_divider_color=&#8221;#FFFFFF&#8221; top_divider_height=&#8221;71px&#8221; top_divider_repeat=&#8221;1x&#8221; top_divider_flip=&#8221;vertical&#8221; top_divider_style_tablet=&#8221;&#8221; top_divider_style_phone=&#8221;none&#8221; top_divider_style_last_edited=&#8221;on|desktop&#8221; global_module=&#8221;3442&#8243; saved_tabs=&#8221;all&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_row _builder_version=&#8221;4.24.0&#8243; _module_preset=&#8221;default&#8221; width=&#8221;70%&#8221; max_width=&#8221;100%&#8221; custom_margin=&#8221;-50px||||false|false&#8221; custom_padding=&#8221;||||false|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.24.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_image src=&#8221;https:\/\/kyowakirininternational.com\/pt-pt\/wp-content\/uploads\/sites\/22\/2024\/01\/KKI-Logo-White-PhotoRoom-1-300&#215;86.png&#8221; title_text=&#8221;KKI Logo White-PhotoRoom&#8221; align=&#8221;center&#8221; _builder_version=&#8221;4.24.0&#8243; _module_preset=&#8221;default&#8221; width=&#8221;200px&#8221; width_tablet=&#8221;15%&#8221; width_phone=&#8221;50%&#8221; width_last_edited=&#8221;on|phone&#8221; module_alignment=&#8221;center&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_image][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_2,1_6,1_6,1_6&#8243; _builder_version=&#8221;4.24.0&#8243; _module_preset=&#8221;default&#8221; width=&#8221;70%&#8221; max_width=&#8221;100%&#8221; custom_padding=&#8221;||27px|||&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.24.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; text_text_color=&#8221;#FFFFFF&#8221; header_4_text_color=&#8221;#FFFFFF&#8221; width=&#8221;100%&#8221; max_width=&#8221;100%&#8221; custom_padding=&#8221;5px|10px|5px|10px|false|false&#8221; border_width_all=&#8221;1px&#8221; border_color_all=&#8221;#FFFFFF&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p style=\"text-align: center;\"><span style=\"color: #ffffff;\">COMUNIQUE AQUI <a href=\"https:\/\/kyowakirininternational.com\/global-reporting\/\" title=\"COMUNIQUE AQUI OS EVENTOS ADVERSOS\" target=\"_blank\" style=\"color: #ffffff;\" rel=\"noopener\">OS EVENTOS ADVERSOS<\/a><\/span><\/p>\n<p>[\/et_pb_text][et_pb_text content_tablet=&#8221;&#8221; content_phone=&#8221;&#8221; content_last_edited=&#8221;on|phone&#8221; module_class=&#8221;my-popup2&#8243; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; text_font=&#8221;||||||||&#8221; text_text_color=&#8221;#E02B20&#8243; text_orientation=&#8221;center&#8221; custom_margin=&#8221;||||false|false&#8221; custom_margin_tablet=&#8221;&#8221; custom_margin_phone=&#8221;-50px||||false|false&#8221; custom_margin_last_edited=&#8221;on|desktop&#8221; custom_padding=&#8221;||||false|false&#8221; text_font_size_tablet=&#8221;&#8221; text_font_size_phone=&#8221;&#8221; text_font_size_last_edited=&#8221;on|phone&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p style=\"text-align: left;\"><span style=\"color: #ffffff;\"><a href=\"https:\/\/clinicaltrials.gov\/search?term=Kyowa%20Kirin&amp;city=\" target=\"_blank\" rel=\"noopener\" style=\"color: #ffffff;\">Clique aqui para pesquisar os ensaios cl\u00ednicos da Kyowa Kirin<\/a><\/span><\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_6&#8243; _builder_version=&#8221;4.24.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; text_font=&#8221;||||||||&#8221; text_text_color=&#8221;#FFFFFF&#8221; text_font_size=&#8221;16px&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p><span style=\"color: #ffffff;\"><a href=\"https:\/\/kyowakirininternational.com\/pt-pt\/noticias-e-recursos\/\" style=\"color: #ffffff;\">Not\u00edcias e recursos<\/a><\/span><br \/><span style=\"color: #ffffff;\"><a href=\"https:\/\/kyowakirininternational.com\/pt-pt\/pessoas-e-carreiras\/\" style=\"color: #ffffff;\">Carreiras<\/a><\/span><\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_6&#8243; _builder_version=&#8221;4.24.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; text_text_color=&#8221;#FFFFFF&#8221; text_font_size=&#8221;16px&#8221; text_text_color_tablet=&#8221;&#8221; text_text_color_phone=&#8221;&#8221; text_text_color_last_edited=&#8221;on|desktop&#8221; global_colors_info=&#8221;{}&#8221; text_text_color__hover_enabled=&#8221;on|desktop&#8221; text_text_color__hover=&#8221;#FFFFFF&#8221;]<\/p>\n<p><span style=\"color: #ffffff;\"><a href=\"https:\/\/kyowakirininternational.com\/pt-pt\/global-reporting\/\" target=\"_blank\" style=\"color: #ffffff;\" rel=\"noopener\">Relat\u00f3rios<\/a><\/span><br \/><span style=\"color: #ffffff;\"><a href=\"https:\/\/kyowakirininternational.com\/pt-pt\/quem-somos\/responsabilidade\/\" style=\"color: #ffffff;\">Responsabilidade<\/a><\/span><\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_6&#8243; _builder_version=&#8221;4.24.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; width=&#8221;70%&#8221; max_width=&#8221;100%&#8221; custom_padding=&#8221;||||false|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.24.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; text_text_color=&#8221;#FFFFFF&#8221; header_text_color=&#8221;#FFFFFF&#8221; header_4_text_color=&#8221;#FFFFFF&#8221; header_6_text_color=&#8221;#FFFFFF&#8221; width=&#8221;100%&#8221; max_width=&#8221;100%&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4><a href=\"https:\/\/kyowakirininternational.com\/pt-pt\/quem-somos\/\" title=\"SOBRE N\u00d3S\">SOBRE N\u00d3S<\/a>\u00a0 |\u00a0 <a href=\"https:\/\/kyowakirininternational.com\/pt-pt\/contacte-nos\/\" title=\"CONTACTE-NOS\">CONTACTE-NOS<\/a>\u00a0 |\u00a0 <a href=\"https:\/\/kyowakirininternational.com\/pt-pt\/AVISOS\/\" title=\"AVISOS\">AVISOS<\/a>\u00a0 |\u00a0 <a href=\"https:\/\/kyowakirininternational.com\/pt-pt\/AVISOS\/\" title=\"TERMOS DE UTILIZA\u00c7\u00c3O\">TERMOS DE UTILIZA\u00c7\u00c3O<\/a><\/p>\n<p><a href=\"https:\/\/kyowakirininternational.com\/pt-pt\/AVISOS\/\" title=\"Modern Slavery Act\">MODERN SLAVERY ACT<\/a> | <a href=\"https:\/\/kyowakirininternational.com\/pt-pt\/AVISOS\/\" title=\"C\u00d3DIGO DE CONDUTA DE TERCEIROS\">C\u00d3DIGO DE CONDUTA DE TERCEIROS<\/a><\/h4>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; width=&#8221;70%&#8221; max_width=&#8221;100%&#8221; custom_margin=&#8221;-30px||||false|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.24.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; text_text_color=&#8221;#FFFFFF&#8221; width=&#8221;100%&#8221; max_width=&#8221;100%&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p><span><\/span><\/p>\n<p>Direitos de autor \u00a9 Kyowa Kirin International plc. Todos os direitos reservados.\u00a0Este site \u00e9 desenvolvido e financiado pela Kyowa Kirin International plc.<\/p>\n<p>A Kyowa Kirin International plc \u00e9 uma empresa registada na Esc\u00f3cia (com o n\u00famero SC198780) com sede social em Galabank Business Park, Galashiels TD1 1QH, Reino Unido.<\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; background_color=&#8221;#5d6164&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_row _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; width=&#8221;70%&#8221; max_width=&#8221;100%&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; text_text_color=&#8221;#FFFFFF&#8221; custom_margin=&#8221;-100px||||false|false&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p>KKI\/PT\/CORP\/0003<\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>As a Japan-based global specialty pharmaceutical company, we are committed to delivering medicines and treatments with life-changing value for people impacted by under-diagnosed and under-served diseases.<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":888,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"class_list":["post-895","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.2 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Under-diagnosed and under-served diseases we treat | Kyowa Kirin<\/title>\n<meta name=\"description\" content=\"Kyowa Kirin: Pioneering Treatments for Rare Diseases like CTCL, XLH, MLD &amp; More. Explore innovative solutions for under-diagnosed and under-served conditions.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/kyowakirininternational.com\/pt-pt\/o-que-fazemos\/areas-de-foco\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"\u00c1reas de foco\" \/>\n<meta property=\"og:description\" content=\"Kyowa Kirin: Pioneering Treatments for Rare Diseases like CTCL, XLH, MLD &amp; More. Explore innovative solutions for under-diagnosed and under-served conditions.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/kyowakirininternational.com\/pt-pt\/o-que-fazemos\/areas-de-foco\/\" \/>\n<meta property=\"og:site_name\" content=\"Kyowa Kirin International - PT\" \/>\n<meta property=\"article:modified_time\" content=\"2025-10-09T13:56:17+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/kyowakirininternational.com\/pt-pt\/wp-content\/uploads\/sites\/22\/2024\/01\/Link-to-external-1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"26\" \/>\n\t<meta property=\"og:image:height\" content=\"28\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/kyowakirininternational.com\/pt-pt\/o-que-fazemos\/areas-de-foco\/\",\"url\":\"https:\/\/kyowakirininternational.com\/pt-pt\/o-que-fazemos\/areas-de-foco\/\",\"name\":\"Under-diagnosed and under-served diseases we treat | Kyowa Kirin\",\"isPartOf\":{\"@id\":\"https:\/\/kyowakirininternational.com\/pt-pt\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/kyowakirininternational.com\/pt-pt\/o-que-fazemos\/areas-de-foco\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/kyowakirininternational.com\/pt-pt\/o-que-fazemos\/areas-de-foco\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/kyowakirininternational.com\/pt-pt\/wp-content\/uploads\/sites\/22\/2024\/01\/Link-to-external-1.png\",\"datePublished\":\"2024-02-01T13:27:48+00:00\",\"dateModified\":\"2025-10-09T13:56:17+00:00\",\"description\":\"Kyowa Kirin: Pioneering Treatments for Rare Diseases like CTCL, XLH, MLD & More. Explore innovative solutions for under-diagnosed and under-served conditions.\",\"breadcrumb\":{\"@id\":\"https:\/\/kyowakirininternational.com\/pt-pt\/o-que-fazemos\/areas-de-foco\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/kyowakirininternational.com\/pt-pt\/o-que-fazemos\/areas-de-foco\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/kyowakirininternational.com\/pt-pt\/o-que-fazemos\/areas-de-foco\/#primaryimage\",\"url\":\"https:\/\/kyowakirininternational.com\/pt-pt\/wp-content\/uploads\/sites\/22\/2024\/01\/Link-to-external-1.png\",\"contentUrl\":\"https:\/\/kyowakirininternational.com\/pt-pt\/wp-content\/uploads\/sites\/22\/2024\/01\/Link-to-external-1.png\",\"width\":26,\"height\":28},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/kyowakirininternational.com\/pt-pt\/o-que-fazemos\/areas-de-foco\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/kyowakirininternational.com\/pt-pt\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"O que fazemos\",\"item\":\"https:\/\/kyowakirininternational.com\/pt-pt\/o-que-fazemos\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"\u00c1reas de foco\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/kyowakirininternational.com\/pt-pt\/#website\",\"url\":\"https:\/\/kyowakirininternational.com\/pt-pt\/\",\"name\":\"Kyowa Kirin International - PT\",\"description\":\"A Specialty Pharmaceutical Company\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/kyowakirininternational.com\/pt-pt\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Under-diagnosed and under-served diseases we treat | Kyowa Kirin","description":"Kyowa Kirin: Pioneering Treatments for Rare Diseases like CTCL, XLH, MLD & More. Explore innovative solutions for under-diagnosed and under-served conditions.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/kyowakirininternational.com\/pt-pt\/o-que-fazemos\/areas-de-foco\/","og_locale":"en_GB","og_type":"article","og_title":"\u00c1reas de foco","og_description":"Kyowa Kirin: Pioneering Treatments for Rare Diseases like CTCL, XLH, MLD & More. Explore innovative solutions for under-diagnosed and under-served conditions.","og_url":"https:\/\/kyowakirininternational.com\/pt-pt\/o-que-fazemos\/areas-de-foco\/","og_site_name":"Kyowa Kirin International - PT","article_modified_time":"2025-10-09T13:56:17+00:00","og_image":[{"width":26,"height":28,"url":"https:\/\/kyowakirininternational.com\/pt-pt\/wp-content\/uploads\/sites\/22\/2024\/01\/Link-to-external-1.png","type":"image\/png"}],"twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/kyowakirininternational.com\/pt-pt\/o-que-fazemos\/areas-de-foco\/","url":"https:\/\/kyowakirininternational.com\/pt-pt\/o-que-fazemos\/areas-de-foco\/","name":"Under-diagnosed and under-served diseases we treat | Kyowa Kirin","isPartOf":{"@id":"https:\/\/kyowakirininternational.com\/pt-pt\/#website"},"primaryImageOfPage":{"@id":"https:\/\/kyowakirininternational.com\/pt-pt\/o-que-fazemos\/areas-de-foco\/#primaryimage"},"image":{"@id":"https:\/\/kyowakirininternational.com\/pt-pt\/o-que-fazemos\/areas-de-foco\/#primaryimage"},"thumbnailUrl":"https:\/\/kyowakirininternational.com\/pt-pt\/wp-content\/uploads\/sites\/22\/2024\/01\/Link-to-external-1.png","datePublished":"2024-02-01T13:27:48+00:00","dateModified":"2025-10-09T13:56:17+00:00","description":"Kyowa Kirin: Pioneering Treatments for Rare Diseases like CTCL, XLH, MLD & More. Explore innovative solutions for under-diagnosed and under-served conditions.","breadcrumb":{"@id":"https:\/\/kyowakirininternational.com\/pt-pt\/o-que-fazemos\/areas-de-foco\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/kyowakirininternational.com\/pt-pt\/o-que-fazemos\/areas-de-foco\/"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/kyowakirininternational.com\/pt-pt\/o-que-fazemos\/areas-de-foco\/#primaryimage","url":"https:\/\/kyowakirininternational.com\/pt-pt\/wp-content\/uploads\/sites\/22\/2024\/01\/Link-to-external-1.png","contentUrl":"https:\/\/kyowakirininternational.com\/pt-pt\/wp-content\/uploads\/sites\/22\/2024\/01\/Link-to-external-1.png","width":26,"height":28},{"@type":"BreadcrumbList","@id":"https:\/\/kyowakirininternational.com\/pt-pt\/o-que-fazemos\/areas-de-foco\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/kyowakirininternational.com\/pt-pt\/"},{"@type":"ListItem","position":2,"name":"O que fazemos","item":"https:\/\/kyowakirininternational.com\/pt-pt\/o-que-fazemos\/"},{"@type":"ListItem","position":3,"name":"\u00c1reas de foco"}]},{"@type":"WebSite","@id":"https:\/\/kyowakirininternational.com\/pt-pt\/#website","url":"https:\/\/kyowakirininternational.com\/pt-pt\/","name":"Kyowa Kirin International - PT","description":"A Specialty Pharmaceutical Company","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/kyowakirininternational.com\/pt-pt\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"}]}},"_links":{"self":[{"href":"https:\/\/kyowakirininternational.com\/pt-pt\/wp-json\/wp\/v2\/pages\/895","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/kyowakirininternational.com\/pt-pt\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/kyowakirininternational.com\/pt-pt\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/kyowakirininternational.com\/pt-pt\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/kyowakirininternational.com\/pt-pt\/wp-json\/wp\/v2\/comments?post=895"}],"version-history":[{"count":34,"href":"https:\/\/kyowakirininternational.com\/pt-pt\/wp-json\/wp\/v2\/pages\/895\/revisions"}],"predecessor-version":[{"id":3511,"href":"https:\/\/kyowakirininternational.com\/pt-pt\/wp-json\/wp\/v2\/pages\/895\/revisions\/3511"}],"up":[{"embeddable":true,"href":"https:\/\/kyowakirininternational.com\/pt-pt\/wp-json\/wp\/v2\/pages\/888"}],"wp:attachment":[{"href":"https:\/\/kyowakirininternational.com\/pt-pt\/wp-json\/wp\/v2\/media?parent=895"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}